Is Oral XEN-D0501 the Next Obesity Drug Hype?
23 Dec 2024 13:57 PM IST
XEN-D0501, a novel oral tablet targeting the TRPV1 receptor, is generating significant buzz in the pharmaceutical world for its potential to tackle a range of conditions, including obesity, type 2 diabetes, and cardiovascular diseases. This surge in interest stems from the pioneering work of Dorte X. Gram, PhD, founder of